Drugs / MCN36
last change Mar 2009 re-read 3 minutes ago

MCN36

Developed for
bipolar disorder
Investigated by
Alberta Innovation and Science · University of Calgary

Trials 1

20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT00109577 Apr 2005 → Mar 2009 bipolar disorder University of Calgary Terminated No outcome recorded Stop: Enrollment

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as MCN36 ClinicalTrials.gov intervention name — accepted as the source's own label NCT00109577 ↗